Artificial Intelligence and Big Data will be the two most impactful technologies for the pharmaceutical industry for the fourth year in a row in 2023, according to a survey by GlobalData.
GlobalData’s “The State of the Biopharmaceutical Industry – 2023” reveals that AI and Big Data have been trending as the two most disruptive emerging technologies since 2020, with a significant margin from the third choice in all four years.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Asian stocks slip as cautious investors await rates decisionsBig week includes central bank meetings and batch of earnings reports and economic data
Прочитайте больше »